Charles Schwab Trust Co cut its stake in shares of Procter & Gamble Company (The) (NYSE:PG – Free Report) by 33.2% in the 2nd quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 9,210 shares of the company’s stock after selling 4,575 shares during the period. Charles Schwab Trust Co’s holdings in Procter & Gamble were worth $1,467,000 as of its most recent SEC filing.
Other large investors have also added to or reduced their stakes in the company. Hengehold Capital Management LLC boosted its holdings in Procter & Gamble by 0.9% in the 2nd quarter. Hengehold Capital Management LLC now owns 400,717 shares of the company’s stock valued at $63,842,000 after purchasing an additional 3,386 shares during the period. KG&L Capital Management LLC grew its position in shares of Procter & Gamble by 5.5% in the 2nd quarter. KG&L Capital Management LLC now owns 99,560 shares of the company’s stock worth $15,860,000 after buying an additional 5,205 shares during the last quarter. CogentBlue Wealth Advisors LLC raised its position in Procter & Gamble by 27.0% during the second quarter. CogentBlue Wealth Advisors LLC now owns 1,931 shares of the company’s stock worth $308,000 after acquiring an additional 411 shares during the period. Tempus Wealth Planning LLC boosted its stake in shares of Procter & Gamble by 13.4% in the second quarter. Tempus Wealth Planning LLC now owns 1,954 shares of the company’s stock valued at $311,000 after purchasing an additional 231 shares during the period. Finally, TOWER TRUST & INVESTMENT Co increased its holdings in shares of Procter & Gamble by 1.6% in the 2nd quarter. TOWER TRUST & INVESTMENT Co now owns 4,943 shares of the company’s stock valued at $787,000 after acquiring an additional 77 shares during the period. Institutional investors own 65.77% of the company’s stock.
Procter & Gamble Stock Up 0.2%
Shares of NYSE:PG opened at $152.44 on Friday. The stock has a market capitalization of $356.78 billion, a price-to-earnings ratio of 23.42, a price-to-earnings-growth ratio of 4.02 and a beta of 0.36. The company has a debt-to-equity ratio of 0.49, a quick ratio of 0.49 and a current ratio of 0.70. The company’s fifty day moving average is $156.00 and its two-hundred day moving average is $160.55. Procter & Gamble Company has a 1-year low of $149.91 and a 1-year high of $180.43.
Procter & Gamble Dividend Announcement
The business also recently declared a quarterly dividend, which was paid on Friday, August 15th. Shareholders of record on Friday, July 18th were paid a $1.0568 dividend. This represents a $4.23 dividend on an annualized basis and a yield of 2.8%. The ex-dividend date of this dividend was Friday, July 18th. Procter & Gamble’s payout ratio is 64.98%.
Insiders Place Their Bets
In related news, CEO Sundar G. Raman sold 9,554 shares of the firm’s stock in a transaction on Thursday, August 21st. The stock was sold at an average price of $158.16, for a total value of $1,511,060.64. Following the completion of the transaction, the chief executive officer owned 41,886 shares in the company, valued at $6,624,689.76. This trade represents a 18.57% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available at this link. Also, CEO Gary A. Coombe sold 10,194 shares of Procter & Gamble stock in a transaction that occurred on Thursday, August 21st. The shares were sold at an average price of $158.16, for a total transaction of $1,612,283.04. Following the sale, the chief executive officer directly owned 34,978 shares in the company, valued at approximately $5,532,120.48. The trade was a 22.57% decrease in their position. The disclosure for this sale can be found here. In the last ninety days, insiders sold 120,181 shares of company stock valued at $18,918,012. Company insiders own 0.20% of the company’s stock.
Analysts Set New Price Targets
PG has been the topic of a number of recent research reports. Berenberg Bank raised their target price on Procter & Gamble from $152.00 to $154.00 and gave the company a “hold” rating in a research note on Wednesday, September 17th. BNP Paribas Exane decreased their target price on Procter & Gamble from $177.00 to $172.00 and set an “outperform” rating for the company in a research report on Tuesday, September 23rd. Wells Fargo & Company reduced their target price on Procter & Gamble from $173.00 to $170.00 and set an “overweight” rating on the stock in a research note on Thursday. BNP Paribas restated an “outperform” rating and issued a $177.00 price objective on shares of Procter & Gamble in a report on Friday, August 15th. Finally, Evercore ISI restated an “in-line” rating and set a $170.00 target price (down from $190.00) on shares of Procter & Gamble in a research report on Monday, July 14th. One research analyst has rated the stock with a Strong Buy rating, eleven have given a Buy rating and eight have given a Hold rating to the company’s stock. According to MarketBeat.com, Procter & Gamble has a consensus rating of “Moderate Buy” and an average price target of $173.68.
Procter & Gamble Profile
Procter & Gamble Co engages in the provision of branded consumer packaged goods. It operates through the following segments: Beauty, Grooming, Health Care, Fabric and Home Care, and Baby, Feminine and Family Care. The Beauty segment offers hair, skin, and personal care. The Grooming segment consists of shave care like female and male blades and razors, pre and post shave products, and appliances.
See Also
- Five stocks we like better than Procter & Gamble
- Asset Allocation Strategies in Volatile Markets
- 3 Healthcare Stocks Using AI to Drive Growth
- What is the NASDAQ Stock Exchange?
- Get Exposure to Millennials’ Purchasing Power With This ETF
- Manufacturing Stocks Investing
- Why a $4.5 Billion Smart Debt Move Is Fueling Dell’s AI Ambitions
Want to see what other hedge funds are holding PG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Procter & Gamble Company (The) (NYSE:PG – Free Report).
Receive News & Ratings for Procter & Gamble Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Procter & Gamble and related companies with MarketBeat.com's FREE daily email newsletter.